NFKB1 and prostate carcinoma: For instance, Shankar et al. (2017) reported that betulinic acid, a potential therapeutic compound, induces apoptosis in prostate cancer cells by inhibiting NF-κB signaling, thereby preventing its translocation to the nucleus [6].